Recent Posts
- Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development
- Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
- Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
- Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors
- Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million